Furthermore, we also observed that non-T cells (CD3−) from patients with IIM may also contribute for the elevated levels of IL-6 in these patients (Figure 2K), which may include dendritic cells and monocytes, among others. Here, IL6 is linked to acquired idiopathic inflammatory myopathy.